Kingfa Science & Technology (India) Ltd
Kingfa Science & Technology (India) Ltd
Industrial ProductsKey Fundamentals
MicrocapPlastic Products - IndustrialIndustrial ProductsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Kingfa Science & Technology (India) Ltd insights
29 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
5- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 103% CAGR over last 5 years
- Company's median sales growth is 16.9% of last 10 years
Weaknesses
1- Promoter holding has decreased over last 3 years: -7.97%
Growth Rate
AI Analysis — Bull vs Bear
Kingfa Science & Technology (India) Ltd is a Rs 6,912 Cr market cap industrials company trading at a PE of 37.6x with strong historical profit growth of 103% CAGR over 5 years and 12% sales CAGR over 3 years. The company is virtually debt-free but trades at a premium valuation of 4.98x price-to-book with a negligible 0.2% dividend yield despite consistent profitability.
- Exceptional 5-year compounded profit growth of 103% CAGR demonstrates strong earnings scalability
- Company is almost debt-free, providing financial flexibility and lower interest cost burden
- Consistent ROE averaging 19% over 5 years and 20% over 3 years indicates efficient capital deployment
- 10-year median sales growth of 16.9% reflects sustained demand for its specialty polymer products
- TTM profit growth of 21% shows continued earnings momentum even on a larger base
- 5-year stock CAGR of 34% reflects sustained re-rating driven by improving fundamentals
- Active debt reduction strategy has strengthened the balance sheet and reduced financial risk
- TTM sales growth of 14% indicates the top-line continues to expand in the current period
- PE of 37.6x is elevated for an industrials company, leaving limited margin of safety if growth slows
- Promoter holding has declined by 7.97% over 3 years, signaling potential reduced insider confidence
- Dividend yield of just 0.2% despite repeated profits suggests poor capital return to minority shareholders
- Price-to-book of 4.98x is steep relative to historical book value, implying high expectations are priced in
- 3-year sales CAGR of 12% is notably lower than the 5-year CAGR of 26%, indicating a deceleration in top-line growth
- Last year ROE of 17% has declined from the 3-year average of 20%, showing some pressure on return ratios
- 1-year stock CAGR of 50% significantly outpaces TTM profit growth of 21%, suggesting valuation has run ahead of fundamentals
- As a subsidiary of a Chinese parent, the company faces geopolitical and regulatory risks specific to Indo-China business relations
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- No promoter share encumbrance Jun 15
Kingfa Science & Technology (India) Ltd disclosed to BSE and NSE that promoters created no encumbrance on shares during FY26, indicating clean promoter holdings.
TL;DR: Limited news flow for Kingfa Science & Technology with only a routine regulatory disclosure confirming no promoter share pledging in FY26. No identifiable headwinds or positive catalysts from recent coverage. The lack of news makes it difficult to assess whether the trend is improving or deteriorating; investors should watch for upcoming quarterly results and operational updates for directional cues.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 339 | 351 | 394 | 404 | 416 | 418 | 440 | 470 | 462 | 466 | 489 | 578 | 689 |
| Expenses | 289 | 306 | 356 | 354 | 359 | 362 | 389 | 409 | 404 | 405 | 428 | 497 | 578 |
| Operating Profit | 50 | 45 | 38 | 51 | 57 | 56 | 51 | 60 | 58 | 61 | 62 | 81 | 111 |
| OPM % | 15% | 13% | 10% | 13% | 14% | 13% | 12% | 13% | 13% | 13% | 13% | 14% | 16% |
| Other Income | 2 | 0 | 1 | 2 | 2 | 1 | 5 | 2 | 4 | 3 | 7 | 7 | 5 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 8 | 8 |
| PBT | 47 | 40 | 32 | 45 | 52 | 50 | 49 | 54 | 54 | 55 | 61 | 80 | 108 |
| Tax % | 25% | 25% | 25% | 26% | 25% | 26% | 30% | 23% | 26% | 26% | 26% | 26% | 25% |
| Net Profit | 35 | 30 | 24 | 34 | 39 | 37 | 35 | 42 | 40 | 41 | 45 | 59 | 80 |
| EPS in Rs | 28.93 | 24.44 | 20.09 | 27.7 | 32.26 | 30.77 | 28.6 | 34.6 | 32.86 | 30.36 | 33.33 | 43.65 | 59.19 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 219 | 314 | 427 | 602 | 702 | 742 | 627 | 1,048 | 1,404 | 1,488 | 1,745 | 1,996 | 2,222 |
| Expenses | 212 | 288 | 408 | 560 | 666 | 698 | 607 | 966 | 1,276 | 1,303 | 1,520 | 1,734 | 1,908 |
| Operating Profit | 6 | 27 | 19 | 41 | 35 | 43 | 20 | 82 | 128 | 185 | 225 | 261 | 314 |
| OPM % | 3% | 8% | 4.5% | 7% | 5% | 6% | 3.2% | 8% | 9% | 12% | 13% | 13% | 14% |
| Other Income | 0 | 1 | 4 | 6 | 4 | 3 | 6 | -22 | 2 | 3 | 9 | 21 | 22 |
| Interest | 8 | 7 | 2 | 2 | 2 | 4 | 3 | 5 | 7 | 6 | 7 | 4 | 3 |
| Depreciation | 3 | 3 | 3 | 6 | 8 | 9 | 11 | 13 | 14 | 18 | 22 | 28 | 30 |
| PBT | -5 | 17 | 18 | 39 | 29 | 33 | 12 | 41 | 110 | 164 | 206 | 250 | 303 |
| Tax % | -35% | 38% | 30% | 36% | 35% | 26% | 55% | 26% | 26% | 25% | 26% | 26% | — |
| Net Profit | -3 | 11 | 12 | 25 | 19 | 25 | 5 | 31 | 81 | 123 | 153 | 185 | 226 |
| EPS in Rs | -2.49 | 8.93 | 10.24 | 20.35 | 15.74 | 20.33 | 4.39 | 25.29 | 67.22 | 101 | 126 | 137 | 167 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 0% | 0% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 10 | 10 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 14 |
| Reserves | 2 | 109 | 234 | 293 | 312 | 336 | 342 | 372 | 454 | 576 | 716 | 1,386 |
| Borrowings | 75 | 16 | 42 | 21 | 17 | 46 | 71 | 46 | 42 | 33 | 43 | 15 |
| Other Liabilities | 41 | 95 | 119 | 159 | 210 | 202 | 246 | 449 | 502 | 373 | 384 | 339 |
| Total Liabilities | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,156 | 1,754 |
| Fixed Assets | 25 | 29 | 76 | 88 | 85 | 107 | 129 | 126 | 123 | 252 | 244 | 300 |
| CWIP | 1 | 41 | 10 | 2 | 79 | 115 | 123 | 127 | 131 | 2 | 41 | 61 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 99 | 160 | 319 | 395 | 388 | 375 | 419 | 627 | 756 | 740 | 871 | 1,393 |
| Total Assets | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,156 | 1,754 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -1 | 19 | -119 | -116 | 96 | 30 | -2 | 38 | 27 | 16 | 60 | 66 |
| Investing | -4 | -47 | -18 | -6 | -77 | -63 | -14 | -19 | -12 | 2 | -30 | -392 |
| Financing | 5 | 34 | 137 | 14 | -7 | 22 | 17 | -14 | -21 | -8 | -7 | 438 |
| Net Cash Flow | 0 | 6 | -1 | -108 | 12 | -11 | 1 | 5 | -6 | 10 | 23 | 112 |
| Free Cash Flow | -5 | -28 | -138 | -127 | 14 | -35 | -17 | 19 | 3 | -5 | 30 | -45 |
| CFO/OP | -13 | 72 | -602 | -256 | 300 | 111 | 5 | 63 | 35 | 29 | 56 | 48 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 93 | 99 | 111 | 110 | 109 | 97 | 123 | 99 | 93 | 99 | 93 | 98 |
| Inventory Days | 64 | 85 | 69 | 85 | 63 | 67 | 100 | 110 | 94 | 76 | 82 | 78 |
| Days Payable | 72 | 127 | 108 | 108 | 119 | 115 | 152 | 181 | 155 | 110 | 94 | 75 |
| Cash Conversion Cycle | 85 | 57 | 72 | 86 | 53 | 49 | 71 | 28 | 32 | 66 | 80 | 100 |
| Working Capital Days | -14 | 66 | 59 | 96 | 59 | 55 | 57 | 39 | 45 | 78 | 85 | 113 |
| ROCE % | 4% | 22% | 9% | 13% | 9% | 10% | 4% | 16% | 25% | 30% | 31% | 23% |
Documents
Frequently Asked Questions about Kingfa Science & Technology (India) Ltd
What does Kingfa Science & Technology (India) Ltd do?
Where is Kingfa Science & Technology (India) Ltd (KINGFA) listed?
Which sector does Kingfa Science & Technology (India) Ltd belong to?
What is the market capitalisation of Kingfa Science & Technology (India) Ltd?
What is the PE ratio of Kingfa Science & Technology (India) Ltd?
What is the 52-week high and low of Kingfa Science & Technology (India) Ltd?
Does Kingfa Science & Technology (India) Ltd pay dividends?
What is the Return on Equity (ROE) of Kingfa Science & Technology (India) Ltd?
How can I research Kingfa Science & Technology (India) Ltd on Tapetide?
Company Information
Kingfa Science & Technology (India) Limited, a subsidiary company of M/s Kingfa Science & Technology Co. Ltd China, is engaged in the business of manufacturing and supply of high-quality modified plastic compounds for automotive and consumer products and personal protective equipments like masks and gloves. [1]